Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2 Thiol L Histidine Betaine
2. 2-thiol-l-histidine-betaine
3. Thioneine
1. L-(+)-ergothioneine
2. 497-30-3
3. L-ergothioneine
4. Sympectothion
5. Ergothionine
6. L-thioneine
7. Thiolhistidine-betaine
8. Thioneine
9. (s)-3-(2-thioxo-2,3-dihydro-1h-imidazol-4-yl)-2-(trimethylammonio)propanoate
10. Bdz3dqm98w
11. 58511-63-0
12. L(+)-ergothioneine
13. Thiasine
14. (2s)-3-(2-sulfanylidene-1,3-dihydroimidazol-4-yl)-2-(trimethylazaniumyl)propanoate
15. (s)-(1-carboxy-2-(2-mercaptoimidazol-4-yl)ethyl)trimethylammonium Hydroxide
16. Unii-bdz3dqm98w
17. Erythrothioneine
18. L-ergothionine
19. Ergothioneine Thiol
20. Ergothioneine Thione
21. Nsc 7175
22. Thiolhistidinebetaine
23. Einecs 207-843-5
24. Mfcd00167474
25. Ergothioneine L-(+)
26. Ergothioneine Thione Form
27. Ai3-23492
28. Ergothioneine [mi]
29. Ergothioneine (thione Form)
30. Ergothioneine [inci]
31. Schembl188140
32. Chebi:4828
33. Schembl9985141
34. Chebi:82707
35. Dtxsid901020082
36. Hms2089d04
37. 2-mercaptohistidine Trimethylbetaine
38. Hy-n1914
39. Ccg-207908
40. 1h-imidazole-4-ethanaminium, .alpha.-carboxy-2,3-dihydro-n,n,n-trimethyl-2-thioxo-, Inner Salt, (.alpha.s)-
41. 1h-imidazole-4-ethanaminium, Alpha-carboxy-2,3-dihydro-n,n,n-trimethyl-2-thioxo-, Inner Salt, (s)-
42. Cs-0018211
43. D83035
44. Ab01275464-01
45. A930109
46. Ergothionine;l-(+)-ergothioneine;erythrothioneine
47. Q614788
48. (2s)-3-(2-mercapto-1h-imidazol-5-yl)-2-(trimethylammonio)propanoate
49. (2s)-3-(2-mercapto-1h-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate
50. 3-(2-sulfanylidene-1,3-dihydroimidazol-4-yl)-2-trimethylammonio-propanoate
51. Nalpha,nalpha,nalpha-trimethyl-2-sulfanylidene-2,3-dihydro-l-histidine
52. (2s)-3-(2-sulfanylidene-2,3-dihydro-1h-imidazol-4-yl)-2-(trimethylazaniumyl)propanoate
53. (2s)-3-(2-thioxo-2,3-dihydro-1h-imidazol-4-yl)-2-(trimethylazaniumyl)propanoate
54. (.alpha.s)-.alpha.-carboxy-2,3-dihydro-n,n,n-trimethyl-2-thioxo-1h-imidazole-4-ethanaminium Inner Salt
55. (alphas)-alpha-carboxy-2,3-dihydro-n,n,n-trimethyl-2-thioxo-1h-imidazole-4-ethanaminium Inner Salt
56. 1h-imidazole-4-ethanaminium, Alpha-carboxy-2,3-dihydro-n,n,n-trimethyl-2-thioxo-, Hydroxide, Inner Salt, (s)-
57. 1h-imidazole-4-ethanaminium, Alpha-carboxy-2,3-dihydro-n,n,n-trimethyl-2-thioxo-, Inner Salt, (alphas)-
58. 1h-imidazole-4-ethaniminium, Alpha-carboxy-2,3-dihydro-n,n,n-trimethyl-2-thioxo-, Hydroxide, Inner Salt, (s)-
59. Ammonium, (1-carboxy-2-(2-mercaptoimidazol-4-yl)ethyl)trimethyl-, Hydroxide, Inner Salt, L-(+)-
| Molecular Weight | 229.30 g/mol |
|---|---|
| Molecular Formula | C9H15N3O2S |
| XLogP3 | 0.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 96.3 |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 314 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A L-Ergothioneine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Ergothioneine, including repackagers and relabelers. The FDA regulates L-Ergothioneine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Ergothioneine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Ergothioneine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Ergothioneine supplier is an individual or a company that provides L-Ergothioneine active pharmaceutical ingredient (API) or L-Ergothioneine finished formulations upon request. The L-Ergothioneine suppliers may include L-Ergothioneine API manufacturers, exporters, distributors and traders.
click here to find a list of L-Ergothioneine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
L-Ergothioneine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Ergothioneine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L-Ergothioneine GMP manufacturer or L-Ergothioneine GMP API supplier for your needs.
A L-Ergothioneine CoA (Certificate of Analysis) is a formal document that attests to L-Ergothioneine's compliance with L-Ergothioneine specifications and serves as a tool for batch-level quality control.
L-Ergothioneine CoA mostly includes findings from lab analyses of a specific batch. For each L-Ergothioneine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Ergothioneine may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Ergothioneine EP), L-Ergothioneine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Ergothioneine USP).
LOOKING FOR A SUPPLIER?
